Full-Time

Senior Customer Training Business Analyst

Updated on 5/26/2026

Intuitive Surgical

Intuitive Surgical

10,001+ employees

Manufactures robotic surgical systems and services

No salary listed

San Francisco, CA, USA

In Person

Category
Business & Strategy (1)
Required Skills
NetSuite
SAP Products
Salesforce
Oracle
Data Analysis
Requirements
  • 5+ years relevant work experience providing system and/or Customer Support environment preferred
  • Strong attention to detail and organizational skills is required
  • Proficient understanding of CRM systems (Salesforce, NetSuite, SAP, etc.), ERP business systems (SAP, Oracle, etc.) and preferably LMS solutions
  • Effective analytical, troubleshooting and problem-solving skills required
  • Ability to work independently, multitask, and prioritize duties
  • Must be capable to work effectively in cross-functional project teams
  • Proficient in all Microsoft Office applications
  • Strong oral and written communication skills, as well as strong interpersonal skills
  • Ability to travel 5-10% including weekends and evenings
  • Bachelor’s degree or 5+ years equivalent related experience
Responsibilities
  • Interact with business partners and stakeholders to understand their needs, gather and document business, user and functional requirements
  • Evaluate “as-is” processes to identify inefficiencies and design “to-be” process
  • Recommend technology solutions, tools, or process changes to meet business needs and align on global best practices
  • Partner with IT teams to provide solutions for efficient coordination of training resources/events and timely enablement of program expansion to other regions and organizations
  • Act as the link between business stakeholders and IT teams to facilitate communication and provide clarification on requirements
  • Support projects/enhancements through test script creation, testing (User Acceptance Testing – UAT), training and implementation of new solutions
  • Liaison with IT on new releases and quarterly updates; evaluate new technology and act as business administrator and first/second level support
  • Provide operational support to internal daily functional responsibilities
  • Meet with internal customers regularly to understand their processes, challenges, and future business direction
  • Analyze production issues to determine root cause and provide recommendations to the IT development team
  • Monitor, track, resolve, and escalate (as appropriate) system/application issues
  • Create and maintain training documentation for new functionality
  • Provide operational and business system training to end users
  • Document and maintain standard operating procedures and associated reference documentation for key processes
  • Develop complex reports for data analysis and trending
Desired Qualifications
  • Experience working with EDI and Business Analysis/Reporting tools (SAP BI, Tableau, etc.) are preferred

Intuitive Surgical designs, manufactures, and sells robotic surgical systems and provides related services and accessories for minimally invasive surgery. The core product helps surgeons perform operations with enhanced precision by guiding robotic arms controlled from a console, allowing procedures to be done through small incisions. Instruments and consumables are used with the systems and are supported by service contracts, creating a recurring revenue stream. Compared to competitors, Intuitive has a large installed base and focuses specifically on robotic-assisted surgery, combining devices, disposable instruments, and ongoing services to support hospitals and surgical centers. Its goal is to improve patient outcomes by enabling safer, less invasive procedures while expanding the use and capabilities of robotic surgery for more procedures and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 procedures grew 17%, supporting system placements and consumables.[1]
  • Da Vinci 5 adoption is accelerating, with 232 systems placed in Q1 2026.[1]
  • Remote collaboration features can improve surgeon training and hospital efficiency.[1][3]

What critics are saying

  • FDA Class II recalls expose core instruments to revenue disruption and scrutiny.[5]
  • Regulatory delays can slow rollout of new da Vinci 5 features.[1][2]
  • A larger installed base raises replacement-cycle dependence and capex sensitivity.[1][4]

What makes Intuitive Surgical unique

  • da Vinci 5 adds over 100 workflow and security updates.[2][3]
  • Ion and da Vinci span both soft-tissue and endoluminal procedures.[2]
  • Recurring instruments and service revenue deepen Intuitive's installed-base advantage.[2][4]

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Intuitive Surgical who can refer or advise you

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Apr 7th, 2026
Intuitive Surgical emerges as dark horse in anti-obesity market as surgery outperforms GLP-1 drugs

Intuitive Surgical could emerge as a dark horse in the anti-obesity market as bariatric surgery proves more effective than GLP-1 drugs for long-term weight loss. A recent study of over 50,000 patients found surgery patients lost an average of 58 pounds after two years, compared to just 12 pounds for those using GLP-1 medications. The study also showed surgery delivers more sustainable results. Gastric bypass patients maintain around 52% of their excess weight loss after 10 years, whilst GLP-1 users often regain all lost weight after stopping treatment. Intuitive's da Vinci surgical system offers minimally invasive bariatric surgery options. The company generated $10.1 billion in revenue last year, up from $8.4 billion, with profit margins around 28%. Despite shares falling over 20% this year, the company's position in surgical innovation makes it a compelling long-term investment.

Yahoo Finance
Mar 29th, 2026
Intuitive Surgical shares drop 19% YTD, but analysts see 15% upside potential

Intuitive Surgical has experienced recent share price weakness, declining 3% in one day with negative returns over the past week, month and three months. The stock currently trades at $452.66, down 10.1% over one month and 19.45% year-to-date, though three-year total shareholder returns remain strong at 77.19%. The medical technology company reports annual revenue of $10.1 billion and net income of $2.9 billion, maintaining a dominant position in minimally invasive surgical technology. According to one valuation analysis, Intuitive Surgical's fair value sits at $532.46, suggesting the stock is undervalued by approximately 15% at current levels. The analysis projects 12% annual revenue growth over the next five years, supported by recurring revenues from spare parts and software licences, with profit margins expected to reach 30% from the current 28.6%.

Yahoo Finance
Mar 28th, 2026
Intuitive Surgical shares up 23% after Jim Cramer's buy recommendation

Intuitive Surgical shares rose 23% following Jim Cramer's recommendation on CNBC's Squawk on the Street in June 2025, where he urged investors to "just go buy ISRG". The medical robotics company experienced a 27% surge in October after reporting third-quarter earnings that beat analyst estimates. Revenue reached $2.51 billion against expectations of $2.40 billion, whilst adjusted earnings per share hit $2.40 versus the predicted $1.98. However, the stock declined 2.7% in January 2026 after Intuitive Surgical released preliminary fourth-quarter results, citing concerns that Medicaid funding cuts and competing products could slow growth of its robotic surgical systems. Despite the recent setback, shares remain up significantly since Cramer's initial endorsement, though they're down 7.8% over the past year.

Yahoo Finance
Mar 28th, 2026
Intuitive Surgical faces tariff headwinds and rising competition despite 19% revenue growth to $2.87B

Intuitive Surgical faces headwinds from tariffs and increased competition in the robotic-assisted surgery market, yet its fundamentals remain strong. The medical device company reported fourth-quarter revenue growth of 19% to $2.87 billion, whilst adjusted earnings per share rose 14.5% to $2.53. Procedures using its da Vinci surgical system increased 17%, with the installed base growing 12% to 11,106 units. However, the stock trades at 47.6 times forward earnings, compared to the healthcare sector average of 17.1. New competition is emerging, with Medtronic's Hugo system recently cleared and Johnson & Johnson expected to launch its own device soon. Despite these challenges, Intuitive Surgical maintains advantages through switching costs and extensive real-world data, whilst the underpenetrated robotic-assisted surgery market offers long-term growth potential.

Yahoo Finance
Mar 24th, 2026
ISRG maintains 37% operating margins in Q4 despite 95 bps tariff drag

Intuitive Surgical maintained a 37% operating margin in Q4 despite tariffs creating a 95 basis point drag, alongside higher facility costs and unfavourable product mix from newer platforms like da Vinci 5 and Ion. The company offset these pressures through product cost reductions, component savings and manufacturing efficiencies. Procedure growth of 18% in Q4 and recurring revenue now comprising 81% of total revenues provided operating leverage. Management's 2026 gross margin guidance of 67-68% suggests continued stability, even as tariff headwinds are expected to increase to roughly 1.2% of revenues. Meanwhile, Boston Scientific expanded adjusted operating margins by 100 basis points to 28% in 2025, though tariffs will offset favourable product mix in 2026. The company expects 50-75 basis points operating margin expansion in 2026 through scale efficiencies and supply-chain optimisation.